Wearifi

News

LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.

News

Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.